News for hackers. Stuff that matters.
Re:Interesting Tech Markets for 2019 by aaavl2821 on Tuesday January 08, 2019 @11:28AM (#18856767)
Biopharma: neuroinflammation, next-gen genetically engineered microbe / cell / gene therapies, gene therapy and cell therapy for neuro and autoimmune disease, small molecules targeting genetically defined neuro, cardiovascular and autoimmune disease, chemogenetics, programming languages for specific parts of the bio stack

$17B invested in bio startups in 2018, very little of it by traditional tech VCs

One $11B exit < 5 years from series a (Juno), one $9B exit ~4 years from series a (avexis), one $8b mkt cap ipo, one $8b exit from ~5 year old company to start 2019 (loxo), multiple smaller billion+ exits, ~50 vc backed IPOs

Several innovative companies launching their first drugs soon, potential to become standalone commercial companies: sage, agios, alnylam, Ionis / akcea, bluebird, ultragenyx, gw pharma

Re:Interesting Tech Markets for 2019 by eladgil on Tuesday January 08, 2019 @11:46AM (#18856944)
Good point in terms of mentioning biopharma. I stayed tech focused in this blog post but lots going on in bio.